Ashley King
Speaker Acquisitions Executive
speaking@worldbigroup.com
Drug Discovery
Innovation Programme
From Discovery to Patient Impact
- Date 8–9 September 2027
- Location Basel, Switzerland
Early Bird Avail Now
About the Programme
Experience DDIP Europe 2027
Drug discovery is only the beginning. The real challenge is turning scientific understanding into evidence that can support better development decisions.
DDIP Europe 2027 explores the journey from discovery and target validation through predictive science, translation, development and ultimately toward patient impact.
2 Days
of Scientific & Strategic Discussions
Learn More About DDIP
0+
Drug Discovery Leaders
0+
Industry Speakers
0%
Pharma & Biotech
1:1
Discovery Meetings
Audience — DDIP EU 2027, Basel
Who Will You Meet?
DDIP Europe connects professionals across the wider European discovery ecosystem:
Research & Discovery
Drug Discovery Scientists
R&D Leaders
Translational Researchers
Academia
Research Institutes
Functional Biology Experts
Technology & Development
AI
Computational Biology
Screening
Data & Discovery Platforms
Preclinical
Clinical
Biomarkers
Translational Science
Strategy & Investment
Business Leaders
Investors
Strategic Partners
Reserve Your Place
Register Your Interest
Interest received
Thank you. Our team will follow up with next steps.
Industry Visionaries at DDIP
A Platform of Discovery, Strategy, and Collaboration
Soroush Safaei
Senior Principal Scientist
Sanofi
Olivier Querolle
Senior Director Medicinal Chemistry
FoRx Therapeutics AG
Najy Alsayed MD, M.Sc.
Global Therapeutic Area Head - Infectious Diseases
A. Menarini GmbH
Ricardo Gaminha Pacheco
Longevity Biotechnology Strategic Partnering, BD & L Senior Director
Insilico Medicine
Krzysztof Brzozka
Chief Scientific Officer, Executive Vice President
Ryvu Therapeutics
Elizaveta Solovyeva
Associate Director and Sr Principle Data Scientist
Novartis Biomedical Research
Amir Feizi
Head of Translational AI & Target Discovery
Gero
Dr. Bebeka Cosandey
Lead Scientific Program Manager
University Hospital Basel
Marcel Blommers
CSO
Saverna Therapeutics AG
Trusted By Pharma and Biotech
Leaders Across Europe
Apply for Sponsorship
Frontiers
What is Changing Drug Discovery in Europe?
The Science Behind Better Translation
Six frontiers helping Europe move from discovery insight to stronger development decisions and patient impact.
DDIPEUROPE
Choose Your Pass
Full Event Access
All Sessions
Industry Networking
Non-Service Providers
For Pharma & Biotech
VIP Complimentary Pass Approval required
Limited — Pharma/Biotech only
What Industry Leaders Say
Voices from past delegates across pharma, biotech and discovery science.
Very positively surprised by the high-quality talks! Furthermore, it was a really great and easy to connect with other people! I'd be happy to attend also in future to your events!
It was a great event, well organised with good speakers/panelists and I enjoyed participating. I truly enjoyed the diverse nature of the talks and the networking opportunities at the DDIP.
It was a wonderful event, and I enjoyed chairing it very much. The attendees were positive and I received very nice feedback.
Great organization of the DDIP 26, which I enjoyed a lot. It was also great for networking.
The meticulous background work was the biggest reason for any such events to succeed. Thank you again for inviting me.
The DDIP conference in Basel attracted a highly engaged and attentive audience.
I came away with great questions, fresh perspectives and new connections. Thank you to the DDIP team for the invitation and for putting together such a well-run event.
Always a sign of an interested audience when you see phones coming out to take pictures of the slides, and we saw plenty!
Current Trends in the Pharmaceutical Industry are well covered, including emerging technologies, and evolving market dynamics.
An outstanding conference that brought together diverse pharma experts and delivered valuable insights into drug discovery and product development.
Inspiring and well-organized conference. The agenda has offered a good balance panel moderation and networking.
A nice balance of scientific insights and business development perspectives, providing a well-rounded understanding of the pharmaceutical industry.
Diversity of different types of talks, variety of discussion which you had and interaction of people all across the drug development cycle.
I would definitely recommend this event, it brings many elements useful to look at how AI is really transforming drug discovery.
1 / 20
Contact Our Team
Hannah Jones
Delegate Manager
events@worldbigroup.comMatthew Rose
Sponsorship Manager
sponsorship@worldbigroup.comTina Aston
Media Partnerships Executive
media@worldbigroup.com